Disposition of Participants
(ITT Population)


Xanomeline High Dose

Xanomeline Low Dose

Placebo


n

n

n

Participants randomized

84

84

86

Participants treated

84

84

86

Participants completed

27

25

58

Participants discontinued

57

59

28

Discontinued reason

      Adverse Event

40

44

8

      Death

0

1

2

      I/E Not Met

2

0

1

      Lack of Efficacy

1

0

3

      Lost to Follow-up

0

1

1

      Physician Decision

2

0

1

      Protocol Violation

1

1

1

      Sponsor Decision

3

2

2

      Withdrew Consent

8

10

9

This is footnote

Source:    [Study MK9999P001: adam-adsl]